JENNIFER MCPHAIL: Open Payments
NPI 1780085050 · CHANDLER, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,072 in 53 payments from 15 companies in 2025. Trend: 2023 $749 · 2024 $761 · 2025 $1,072
Food & beverage: $1,072
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $319 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $99 |
| GENZYME CORPORATION | 3 | $90 |
| PFIZER INC. | 5 | $89 |
| Ardelyx, Inc. | 3 | $86 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $82 |
| Madrigal Pharmaceuticals | 3 | $76 |
| Janssen Biotech, Inc. | 2 | $52 |
| Lilly USA, LLC | 2 | $47 |
| QOL Medical, LLC | 1 | $27 |
Products named: RINVOQ, DUPIXENT, IBSRELA, ENTYVIO, REZDIFFRA, VELSIPITY, XIFAXAN, SKYRIZI.
Industry payments across AZ — which companies pay providers there.
